reports
Sunrun Reports Second Quarter 2025 Financial Results
Sunrun Reports Second Quarter 2025 Financial Results Aggregate Subscriber Value of $1.6 billion in Q2, 40% growth year-over-year Contracted Net Value Creation of $376 million, or $1.64 per share, 316% growth year-over-year Net change in cash and restricted cash of $33 million and Cash Generation1 of $27 million in Q2, the fifth consecutive quarter of positive Cash Generation Reiterating Cash Generation guidance of $200 million to $500 million in 2025 SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), America’s largest provider of residential battery storage, solar,...
Esperion Reports Second Quarter 2025 Financial Results and Provides Bu...
Esperion Reports Second Quarter 2025 Financial Results and Provides Business Update – Q2 2025 Total Revenue Grew 12% Y/Y to $82.4 Million – – Q2 2025 U.S. Net Product Revenue Grew 42% Y/Y to $40.3 Million – – Total Retail Prescription Equivalents Increased 10% from First Quarter – – Reached Settlement Agreements with Three ANDA Filers Not to Market Generic Versions of NEXLETOL® (bempedoic acid) Prior to 2040 – – First Quarter of Operating Income from Ongoing Business with Plans for Sustainable Profitability Starting in Q1 2026 – – Conference Call and Webcast Today at 8:00 a.m...
Sunrun Dispatches a Record Amount of Energy to California’s Grid Durin...
Sunrun Dispatches a Record Amount of Energy to California’s Grid During a Historic Event A new analysis confirms Sunrun’s leading position as the largest operator in California’s statewide distributed power plant, delivering 360 megawatts to the state’s grid on a record-setting night SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- A new analysis by The Brattle Group found that Sunrun’s (Nasdaq: RUN) fleet of home batteries across California was the largest contributor to a historic distributed power plant dispatch event that delivered an average of 535 megawatts to the grid—enough to p...
Sunrun and Tesla Launch Home Energy Plan to Cut Costs and Boost Backup...
Sunrun and Tesla Launch Home Energy Plan to Cut Costs and Boost Backup Power for Texans New plan combines Sunrun Flex™ solar + storage with a customized Tesla Electric retail plan to deliver lower rates, seamless backup, and peace of mind for Texas homeowners SAN FRANCISCO, July 24, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, announced today an innovative home energy plan in partnership with retail electric provider Tesla Electric (Nasdaq: TSLA). Created exclusively for ™ customers in Texas, this new home energy...
Esperion to Report Second Quarter 2025 Financial Results on August 5
Esperion to Report Second Quarter 2025 Financial Results on August 5 ANN ARBOR, Mich., July 22, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2025 financial results before the market opens on Tuesday, August 5, 2025. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. A live audio webcast can be accessed on the investor and media section of the Esperion . Access to the webcast replay will be available approximately two hours after completion of the call and...
Sunrun Dispatches Emergency Power to Help Prevent Grid Blackouts Durin...
Sunrun Dispatches Emergency Power to Help Prevent Grid Blackouts During Energy Shortages Amid emergency conditions from summer heat and power generation shortfalls, Sunrun answers urgent utility requests to dispatch energy from home batteries to improve grid reliability SAN FRANCISCO, July 21, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, has begun dispatching more than 37,000 home batteries to provide emergency power to Puerto Rico’s grid operator to address insufficient centralized electricity generation coincid...
Sunrun Prices $431 million Senior Securitization of Residential Solar ...
Sunrun Prices $431 million Senior Securitization of Residential Solar Systems SAN FRANCISCO, July 18, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, today announced it has priced a securitization of leases and power purchase agreements. The securitization is Sunrun’s fourteenth public securitization since 2015 and third issuance in 2025. “Sunrun’s third securitization transaction of 2025 represents a refinancing of a seasoned pool of residential solar assets. We are proud of the strong execution achieved and thank o...
Sunrun Announces Date for Second Quarter 2025 Earnings Report
Sunrun Announces Date for Second Quarter 2025 Earnings Report Earnings Release and Conference Call Scheduled for August 6, 2025 SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN) today announced that it will issue its second quarter 2025 earnings report after the market closes on Wednesday, August 6, 2025. A conference call has been scheduled to discuss these earnings results at 1:30 p.m. Pacific Time. The conference call can be accessed live via the Sunrun Investor Relations website at or over the phone by dialing (877) 407-5989 (toll-free) or (201) 689-8434 (toll)...
Esperion Reaches Settlement Agreement with Third ANDA Filer Not to Mar...
Esperion Reaches Settlement Agreement with Third ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040 ANN ARBOR, Mich., July 08, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Accord Healthcare Inc. This agreement resolves the patent litigation brought by Esperion against Accord Healthcare Inc. in response to Accord Healthcare Inc’s Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of NEXLETOL prior to the expiration of the applicable patents....
Esperion Appoints Craig Thompson to Board of Directors
Esperion Appoints Craig Thompson to Board of Directors Brings More Than Twenty Years of Biopharmaceutical Leadership Experience ANN ARBOR, Mich., July 01, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it has appointed Craig Thompson, Chief Executive Officer of Cerevance, to its Board of Directors. Mr. Thompson will serve as an independent director. With Mr. Thompson’s appointment, Esperion’s Board of Directors now comprises eight members. “We are thrilled to welcome Craig to our Board of Directors. With more than two decades of biopharmaceutical industry leadership a...
Sunrun Dispatches More Than 340 Megawatts of Power in Single Evening t...
Sunrun Dispatches More Than 340 Megawatts of Power in Single Evening to Support the Grid from Coast to Coast As many parts of the country grapple with a triple-digit heat wave, Sunrun answers urgent requests to dispatch critical energy from home batteries paired with solar SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN) announced today that its fleet of home batteries enrolled in distributed power plants dispatched more than 340 megawatts of peak power on the evening of June 24 to support power grids in California, New York, Massachusetts, Rhode Island, and Puerto ...
Sunrun’s Distributed Power Plant Capacity Surpasses 650 Megawatts, Rea...
Sunrun’s Distributed Power Plant Capacity Surpasses 650 Megawatts, Ready to Support Grid Reliability Ahead of Summer Heat and Hurricanes Sunrun is the largest residential energy generating company in America, using batteries paired with solar to improve grid reliability and provide backup power during outages SAN FRANCISCO, June 11, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, today announced that it is activating more than 130,000 home batteries, representing over two-thirds of Sunrun’s total battery fleet, to s...
Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Ma...
Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040 ANN ARBOR, Mich., June 02, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Hetero USA, Inc. and its affiliates Hetero Labs Limited, Hetero Labs Limited Unit-V, and Honour Lab Limited (together, Hetero USA). This agreement resolves the patent litigation brought by Esperion against Hetero USA in response to Hetero USA’ s Abbreviated New Drug Application (ANDA) seeking approval to...
Esperion to Participate in Upcoming June Investor Conferences
Esperion to Participate in Upcoming June Investor Conferences ANN ARBOR, Mich., May 20, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of June, which can be found on our investor relations . Jefferies Global Healthcare Conference in New York on June 4, 2025, at 1:25 p.m. ET. Goldman Sachs Global Healthcare Conference in Miami on June 9, 2025, at 10:40 a.m. ET. Live webcasts can be accessed on the investor and media section of the Esperion . Access to the webcast replay w...
Snap Inc: 3 directors
Three Directors at Snap Inc sold after exercising options/sold 243,139 shares at between 8.542USD and 8.595USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compa...
- Dan Salmon
Sunrun Inc: 1 director
A director at Sunrun Inc bought 50,000 shares at 10.870USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Esperion Reaches Settlement Agreement with ANDA Filer Not to Market Ge...
Esperion Reaches Settlement Agreement with ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040 ANN ARBOR, Mich., May 12, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Micro Labs USA, Inc. and its affiliate Micro Labs Limited (together, Micro Labs). This agreement resolves the patent litigation brought by Esperion against Micro Labs in response to Micro Labs’ Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of NEXLETOL prior to the expiratio...
Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Inv...
Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Investor Conference ANN ARBOR, Mich., May 09, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, 2025, at 10 a.m. ET. The live webcast can be accessed on the investor and media section of the Esperion . Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days. Esperio...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) ANN ARBOR, Mich., May 08, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 7, 2025, the Company granted 15 new employees 49,300 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such individual...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.